Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,925,198
-$120,686 QoQ
Shares Held
477,974
+8.4% QoQ
Ownership
0.791%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. VNDA ranks #189 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,925,198 | 477,974 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,045,884 | 440,794 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,230,460 | 593,023 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $3,181,116 | 637,499 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $4,250,249 | 900,477 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $4,207,742 | 916,720 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,421,008 | 1,340,503 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,891,010 | 616,421 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,809,289 | 497,220 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $6,200,539 | 1,508,648 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $8,536,923 | 2,022,968 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $6,867,197 | 1,589,630 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $6,567,874 | 996,643 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,484,821 | 1,249,606 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,793,394 | 783,951 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,834,014 | 489,273 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,347,010 | 674,038 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $4,670,767 | 412,977 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $4,540,510 | 289,389 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,246,278 | 247,741 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 ALXN | — | 1,725,693 | Shares | Defined | 2021-08-23 | |
| 2021-06-30 | $9,927,617 | 461,535 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 ALXN | — | 1,800,193 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $4,004,151 | 266,588 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 ALXN | — | 1,125,884 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $11,784,778 | 896,863 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 ALXN | — | 646,850 | Shares | Defined | 2020-11-13 | |
| 2020-09-30 | $2,758,411 | 285,550 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 ALXN | — | 523,932 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $2,354,671 | 205,828 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 ALXN | — | 630,677 | Shares | Defined | 2020-05-26 | |
| 2020-03-31 | $6,060,306 | 584,972 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||